William Blair is acting as lead book running manager for the offering.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on VKTX:
- Viking Therapeutics price target raised to $32 from $28 at Truist
- Viking Therapeutics price target raised to $19 from $15 at Roth MKM
- Viking Therapeutics price target raised to $25 from $15 at Maxim
- Viking Therapeutics price target raised to $35 from $12 at Raymond James
- Viking Therapeutics price target raised to $30 from $20 at Oppenheimer